Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Mais filtros

Bases de dados
Tipo de documento
Intervalo de ano de publicação
J Bacteriol ; 172(2): 519-24, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2153655


A system that permits molecular genetic manipulation of mycobacteria was developed on the basis of the yeast paradigm of gene replacement by homologous recombination. A shuttle vector that can replicate autonomously at a high copy number in Escherichia coli but must integrate into homologous DNA for survival in Mycobacterium smegmatis was constructed. The vector contains a ColE1 origin of replication, antibiotic resistance markers for ampicillin and kanamycin, a nutritional marker (pyrF) that allows both positive and negative selection in E. coli and M. smegmatis, and unique restriction sites that permit insertion of foreign DNA. Transformation of mycobacteria with this vector results in integration of its DNA into the genomic pyrF locus by either a single or a double homologous recombination event. With this system, the 65-kilodalton Mycobacterium leprae stress protein antigen was inserted into the M. smegmatis genome and expressed. This gene replacement technology, together with a uniquely useful pyrF marker, should be valuable for investigating mycobacterial pathobiology, for the development of candidate mycobacterial vaccine vehicles, and as a model for the development of molecular genetic systems in other pathogenic microorganisms.

DNA Bacteriano/genética , Escherichia coli/genética , Engenharia Genética/métodos , Mycobacterium/genética , Southern Blotting , Genes Bacterianos , Vetores Genéticos , Biblioteca Genômica , Proteínas de Choque Térmico/genética , Canamicina Quinase , Mycobacterium leprae/genética , Fosfotransferases/genética , Transformação Bacteriana
Proc Natl Acad Sci U S A ; 85(18): 6987-91, 1988 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2842799


Requisite to a detailed understanding of the molecular basis of bacterial pathogenesis is a genetic system that allows for the transfer, mutation, and expression of specific genes. Because of the continuing importance of tuberculosis and leprosy worldwide, we initiated studies to develop a genetic system in mycobacteria and here report the use of two complementary strategies to introduce and express selectable genetic markers. First, an Escherichia coli cosmid was inserted into the temperate mycobacteriophage L1, generating shuttle phasmids replicating as plasmids in E. coli and phage capable of lysogenizing the mycobacterial host. These temperate shuttle phasmids form turbid plaques on Mycobacterium smegmatis and, upon lysogenization, confer resistance to superinfection and integrate within the mycobacterial chromosome. When an L1 shuttle phasmid containing a cloned gene conferring kanamycin resistance in E. coli was introduced into M. smegmatis, stable kanamycin-resistant colonies--i.e., lysogens--were obtained. Second, to develop a plasmid transformation system in mycobacteria, M. fortuitum/E. coli hybrid plasmids containing mycobacterial and E. coli replicons and a kanamycin-resistance gene were constructed. When introduced into M. smegmatis or BCG (Mycobacterium tuberculosis typus bovinus var. Bacille-Calmette-Guérin) by electroporation, these shuttle plasmids conferred stable kanamycin resistance upon transformants. These systems should facilitate genetic analyses of mycobacterial pathogenesis and the development of recombinant mycobacterial vaccines.

Regulação da Expressão Gênica , Lisogenia , Mycobacterium/genética , Transformação Bacteriana , Clonagem Molecular , Escherichia coli/genética , Canamicina Quinase , Hanseníase/microbiologia , Métodos , Mycobacterium/enzimologia , Fosfotransferases/genética , Plasmídeos , Tuberculose/microbiologia
J Bacteriol ; 168(1): 72-80, 1986 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3020007


The ability of "Streptomyces lividans" to use the expression signals of genes from Mycobacterium bovis BCG was tested in vivo by using gene fusions. Random DNA fragments from M. bovis BCG were inserted into promoter-probe plasmids in Escherichia coli and in "S. lividans." Comparison with promoter activity detected with random DNA fragments from the respective hosts suggested that "S. lividans" efficiently utilizes a high proportion of mycobacterial promoters, whereas a smaller fraction are expressed, and expressed more weakly, in E. coli. M. bovis BCG DNA fragments were also inserted into the specially constructed translational fusion vector (pIJ688) in "S. lividans." pIJ688 contains the kanamycin phosphotransferase gene (neo) from transposon Tn5, truncated at its amino terminus, as the indicator. The results suggested that "S. lividans" uses M. bovis BCG translational signals almost as efficiently as its own signals. Moreover, several hybrid proteins with an M. bovis BCG-derived amino terminus seemed to be reasonably stable in "S. lividans." These experiments indicate that "S. lividans" may be a suitable host for the expression of Mycobacterium leprae and Mycobacterium tuberculosis genes from their own signals. This is a precondition for the expression of entire biosynthetic pathways, which could be valuable in the production of diagnostic and therapeutic agents. The vectors may also have wider applications for the analysis of gene expression in Streptomyces.

Clonagem Molecular , Genes Bacterianos , Mycobacterium bovis/genética , Regiões Promotoras Genéticas , Streptomyces/genética , Elementos de DNA Transponíveis , Resistência Microbiana a Medicamentos , Escherichia coli/genética , Canamicina/farmacologia , Canamicina Quinase , Fosfotransferases/biossíntese , Fosfotransferases/genética , Biossíntese de Proteínas , Streptomyces/efeitos dos fármacos , Streptomyces/enzimologia